James D. Lechleiter, PhD, professor of cell systems and anatomy at UT Health San Antonio, and Andrea Giuffrida, PhD, vice president for strategic industry ventures at UT Health San Antonio, were quoted in this story about the first human test of experimental brain injury medication conceived in laboratories at UT Health San Antonio.
